Numerous animal experiments and clinical trials have substantiated the effectiveness of stimulating GLP-1 secretion in the treatment and prevention of obesity [4,5,6,7]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.